These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31544470)

  • 1. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
    Buckley MS; Knutson KD; Agarwal SK; Lansburg JM; Wicks LM; Saggar RC; Richards EC; Kopp BJ; Erstad BL
    Ann Pharmacother; 2020 Feb; 54(2):105-112. PubMed ID: 31544470
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Pharmacist-Led Impact on Inappropriate Albumin Utilization and Associated Costs in General Ward Patients.
    Buckley MS; Agarwal SK; Lansburg JM; Kopp BJ; Erstad BL
    Ann Pharmacother; 2021 Jan; 55(1):44-51. PubMed ID: 32578446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin use guidelines and outcome in a surgical intensive care unit.
    Charles A; Purtill M; Dickinson S; Kraft M; Pleva M; Meldrum C; Napolitano L
    Arch Surg; 2008 Oct; 143(10):935-9; discussion 939. PubMed ID: 18936370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
    Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
    Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Sequential Intervention on Albumin Utilization in Critical Care.
    Lyu PF; Hockenberry JM; Gaydos LM; Howard DH; Buchman TG; Murphy DJ
    Crit Care Med; 2016 Jul; 44(7):1307-13. PubMed ID: 26963324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pharmacists to Improve Patient Care in the Critically Ill: A Large Multicenter Analysis Using Meaningful Metrics With the Medication Regimen Complexity-ICU (MRC-ICU) Score.
    Sikora A; Ayyala D; Rech MA; Blackwell SB; Campbell J; Caylor MM; Condeni MS; DePriest A; Dzierba AL; Flannery AH; Hamilton LA; Heavner MS; Horng M; Lam J; Liang E; Montero J; Murphy D; Plewa-Rusiecki AM; Sacco AJ; Sacha GL; Shah P; Smith MP; Smith Z; Radosevich JJ; Vilella AL;
    Crit Care Med; 2022 Sep; 50(9):1318-1328. PubMed ID: 35678204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted Albumin Utilization Is Safe and Cost Effective in a Cardiac Surgery Intensive Care Unit.
    Rabin J; Meyenburg T; Lowery AV; Rouse M; Gammie JS; Herr D
    Ann Thorac Surg; 2017 Jul; 104(1):42-48. PubMed ID: 28027733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.
    Kessemeier N; Meyn D; Hoeckel M; Reitze J; Culmsee C; Tryba M
    Int J Clin Pharm; 2019 Oct; 41(5):1184-1192. PubMed ID: 31332648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
    Chan LEJ; Soong JL; Lie SA
    Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pharmacy-Based Electronic Handoff Tool to Reduce Discharge Prescribing of Atypical Antipsychotics Initiated in the Intensive Care Unit: A Quality Improvement Initiative.
    Kram BL; Schultheis JM; Kram SJ; Cox CE
    J Pharm Pract; 2019 Aug; 32(4):434-441. PubMed ID: 29486664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Quality Bundle Enforcement by a Critical Care Pharmacist on Patient Outcome and Costs.
    Leguelinel-Blache G; Nguyen TL; Louart B; Poujol H; Lavigne JP; Roberts JA; Muller L; Kinowski JM; Roger C; Lefrant JY
    Crit Care Med; 2018 Feb; 46(2):199-207. PubMed ID: 29189346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds.
    Louzon P; Jennings H; Ali M; Kraisinger M
    Am J Health Syst Pharm; 2017 Feb; 74(4):253-262. PubMed ID: 28179250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
    Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
    Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying Critical Care Pharmacist Interventions in COVID-19.
    Pluenneke JC; Semler MW; Casey JD; Qian ET; Rice TW; Stollings JL
    J Intensive Care Med; 2023 Jul; 38(7):651-656. PubMed ID: 36755415
    [No Abstract]   [Full Text] [Related]  

  • 20. Benefits of pharmacist intervention in the critical care patients with infectious diseases: A propensity score matching retrospective cohort study.
    Gu H; Sun L; Sheng B; Gu X; Wang S; Liu L; Dai B; Chen W
    Aust Crit Care; 2023 Nov; 36(6):933-939. PubMed ID: 36809868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.